Peijia Medical Limited (HKG: 9996)
Hong Kong
· Delayed Price · Currency is HKD 3.900
+0.050 (1.30%)
Nov 15, 2024, 4:08 PM HKT
Peijia Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Revenue | 517.46 | 441.13 | 250.83 | 136.53 | 38.66 | 18.7 | Upgrade
|
| Revenue Growth (YoY) | 44.98% | 75.86% | 83.71% | 253.21% | 106.72% | - | Upgrade
|
| Cost of Revenue | 146.18 | 115.76 | 74.63 | 40.88 | 13.43 | 6.69 | Upgrade
|
| Gross Profit | 371.28 | 325.37 | 176.2 | 95.65 | 25.22 | 12.01 | Upgrade
|
| Selling, General & Admin | 446.33 | 466.62 | 365.06 | 207.68 | 139.1 | 180.85 | Upgrade
|
| Research & Development | 222.61 | 205.5 | 147.02 | 131.3 | 103.37 | 55.13 | Upgrade
|
| Other Operating Expenses | -27.84 | -19.72 | -12.76 | -7.46 | -8.52 | -3.32 | Upgrade
|
| Operating Expenses | 641.1 | 652.4 | 499.32 | 331.52 | 233.95 | 232.66 | Upgrade
|
| Operating Income | -269.82 | -327.03 | -323.12 | -235.87 | -208.72 | -220.65 | Upgrade
|
| Interest Expense | -0.18 | -0.18 | -2.32 | -0.19 | -0.09 | -0.82 | Upgrade
|
| Interest & Investment Income | 33.9 | 39.44 | 46.63 | 24.77 | 37.3 | 2.16 | Upgrade
|
| Earnings From Equity Investments | -0.37 | -0.28 | -0.17 | - | - | - | Upgrade
|
| Currency Exchange Gain (Loss) | -13.9 | -17.78 | 106.42 | -48.14 | -221.24 | -4.2 | Upgrade
|
| Other Non Operating Income (Expenses) | -1.58 | -1.58 | 0.27 | - | -1,676 | -308.18 | Upgrade
|
| EBT Excluding Unusual Items | -251.94 | -307.41 | -172.28 | -259.42 | -2,068 | -531.69 | Upgrade
|
| Gain (Loss) on Sale of Investments | 3.87 | 4.05 | 0.58 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.44 | -0.22 | -0.03 | -0.22 | -0.38 | -0.29 | Upgrade
|
| Other Unusual Items | - | -87.92 | -226.51 | -314.58 | - | - | Upgrade
|
| Pretax Income | -248.51 | -391.5 | -398.24 | -574.22 | -2,069 | -531.98 | Upgrade
|
| Income Tax Expense | 3.25 | 1.05 | 9.57 | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -251.76 | -392.55 | -407.81 | -574.22 | -2,069 | -531.98 | Upgrade
|
| Minority Interest in Earnings | 0.02 | 0.03 | - | - | - | - | Upgrade
|
| Net Income | -251.74 | -392.53 | -407.81 | -574.22 | -2,069 | -531.98 | Upgrade
|
| Net Income to Common | -251.74 | -392.53 | -407.81 | -574.22 | -2,069 | -531.98 | Upgrade
|
| Shares Outstanding (Basic) | 680 | 679 | 673 | 662 | 467 | 228 | Upgrade
|
| Shares Outstanding (Diluted) | 680 | 679 | 673 | 662 | 467 | 228 | Upgrade
|
| Shares Change (YoY) | 0.66% | 0.91% | 1.74% | 41.68% | 104.59% | 25.07% | Upgrade
|
| EPS (Basic) | -0.37 | -0.58 | -0.61 | -0.87 | -4.43 | -2.33 | Upgrade
|
| EPS (Diluted) | -0.37 | -0.58 | -0.61 | -0.87 | -4.43 | -2.33 | Upgrade
|
| Free Cash Flow | -304.08 | -759.11 | -506.61 | -506.11 | -206.35 | -116.06 | Upgrade
|
| Free Cash Flow Per Share | -0.45 | -1.12 | -0.75 | -0.76 | -0.44 | -0.51 | Upgrade
|
| Gross Margin | 71.75% | 73.76% | 70.25% | 70.06% | 65.25% | 64.24% | Upgrade
|
| Operating Margin | -52.14% | -74.14% | -128.82% | -172.75% | -539.97% | -1180.01% | Upgrade
|
| Profit Margin | -48.65% | -88.98% | -162.58% | -420.57% | -5351.59% | -2844.95% | Upgrade
|
| Free Cash Flow Margin | -58.76% | -172.08% | -201.97% | -370.68% | -533.84% | -620.68% | Upgrade
|
| EBITDA | -229.44 | -290.26 | -292.57 | -212.61 | -190.87 | -208.87 | Upgrade
|
| EBITDA Margin | -44.34% | -65.80% | -116.64% | -155.72% | - | - | Upgrade
|
| D&A For EBITDA | 40.38 | 36.77 | 30.54 | 23.26 | 17.85 | 11.78 | Upgrade
|
| EBIT | -269.82 | -327.03 | -323.12 | -235.87 | -208.72 | -220.65 | Upgrade
|
| EBIT Margin | -52.14% | -74.14% | -128.82% | -172.75% | - | - | Upgrade
|
| Advertising Expenses | - | 67.53 | 48.12 | 14.99 | 5.37 | 0.65 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.